
Company Info
Phone(908) 707-1009
Year Established
1981
Ticker
RGEN
Exchange
NASDAQ
Contacts
Tony J. HuntCEO
Jason K. Garland
CFO
James R. Bylund
COO
Olivier Loeillot
President & CEO
Ralf Kuriyel
Senior VP, R&D
Kola Otitoju
Senior VP, Business Development
Company Description
Repligen is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs.